The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Meltzer, H. Y.
* Articles by Fang, V. S.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Meltzer, H. Y.
* Articles by Fang, V. S.

Am J Psychiatry 1979; 136:1550-1555
Copyright © 1979 by American Psychiatric Association


REGULAR ARTICLES

Effect of clozapine on human serum prolactin levels

HY Meltzer, DJ Goode, PM Schyve, M Young and VS Fang

The authors determined serum prolactin levels in 13 patients receiving clozapine, an antipsychotic drug that does not produce extrapyramidal side effects. Morning serum prolactin levels, 11 hours after the last dose, were not elevated during chronic treatment with clozapine in any subject despite its therapeutic effects. Serum prolactin levels were moderately increased between 90 minutes and 4 hours after administration of very high doses of oral clozapine in 4 patients but were smaller than those produced by chlorpromazine in other subjects. The authors suggest that clozapine in other subjects. The authors suggest that clozapine may achieve its antipsychotic effect differently than do classical neuroleptics and that sustained prolactin increases are not essential for antipsychotic action.


This article has been cited by other articles:


Home page
J PsychopharmacolHome page
A. Menon, R. H. M. Williams, and S. Watson
Increased libido associated with quetiapine
J Psychopharmacol, January 1, 2006; 20(1): 125 - 127.
[Abstract] [PDF]


Home page
Br. J. PsychiatryHome page
A. WIECK and P. M. HADDAD
Antipsychotic-induced hyperprolactinaemia in women: pathophysiology, severity and consequences: Selective literature review
The British Journal of Psychiatry, March 1, 2003; 182(3): 199 - 204.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
P. Turrone, S. Kapur, M. V. Seeman, and A. J. Flint
Elevation of Prolactin Levels by Atypical Antipsychotics
Am J Psychiatry, January 1, 2002; 159(1): 133 - 135.
[Abstract] [Full Text] [PDF]


Home page
Psychosom. Med.Home page
J. K. Pal and W. A. Sarino
Effect of Risperidone on Prolactinoma Growth in a Psychotic Woman
Psychosom Med, September 1, 2000; 62(5): 736 - 738.
[Abstract] [Full Text] [PDF]


Home page
Psychiatr. Serv.Home page
R. Mabini, G. Wergowske, and F. M. Baker
Psychopharmacology: Galactorrhea and Gynecomastia in a Hypothyroid Male Being Treated With Risperidone
Psychiatr Serv, August 1, 2000; 51(8): 983 - 985.
[Full Text] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 1979 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org